The totaled health risks in vascular events (THRIVE) score predicts ischemic stroke outcomes independent of thrombolytic therapy in the NINDS tPA Trial
Academic Article
Overview
MeSH Major
Brain Ischemia
Fibrinolytic Agents
Stroke
Thrombolytic Therapy
Tissue Plasminogen Activator
abstract
The THRIVE score provides accurate prediction of long-term neurologic outcomes in patients with acute ischemic stroke regardless of treatment modality. Both the THRIVE score and tPA administration predict outcome, but the THRIVE score does not influence the impact of tPA on outcome, and tPA administration does not influence the impact of THRIVE score on outcome.
